Target intelligence / Profile preview

Epithelial tight junction barrier (TJ)

Target
TJ
Molecular classification
Protein complex, Cell-cell junction, Barrier protein
01

Overview

The epithelial tight junction barrier is a multi-protein complex located at the apical-most part of the lateral intercellular space between epithelial cells. It serves as a primary regulator of the paracellular pathway, controlling the passage of ions, water, and solutes while preventing the translocation of pathogens and toxins (Anderson & Van Itallie, 2009). The structure is composed of transmembrane proteins, including claudins, occludin, and junctional adhesion molecules (JAMs), which interact with intracellular scaffold proteins like zonula occludens (ZO-1) to link the junction to the actin cytoskeleton (Buckley & Turner, 2018). In addition to its gate function, it acts as a fence to maintain cell polarity by separating the apical and basolateral membrane domains. Pathological disruption of the tight junction barrier, often referred to as leaky gut, is implicated in the pathogenesis of various autoimmune and inflammatory diseases, such as celiac disease and inflammatory bowel disease (Fasano, 2011). Therapeutic interventions like larazotide acetate aim to stabilize these junctions or inhibit the signaling pathways that lead to their breakdown, thereby restoring intestinal homeostasis and preventing the entry of inflammatory triggers (Gopalakrishnan et al., 2012).

Other names
Zonula occludensTight junctionIntercellular junctional complexPermeability barrier
02

Mechanism of action

Modulation of paracellular permeability through the antagonism of zonulin signaling, stabilization of transmembrane proteins like claudins and occludin, or the regulation of the perijunctional actomyosin ring to restore or transiently open the barrier.

03

Biological functions

Paracellular transport regulationCell polarity maintenanceBarrier functionSignal transductionIon selectivity
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseAsthmaCancer metastasisType 1 diabetesMultiple sclerosisInfection
05

Safety considerations

Increased systemic absorption of luminal toxins and pathogensElectrolyte and fluid imbalancePotential for uncontrolled systemic inflammationOff-target disruption of blood-organ barriers
06

Interacting drugs

Larazotide acetate

5 more in the full profile.

07

Biomarkers

Serum zonulin levelUrinary claudin-3Transepithelial electrical resistance (TEER)Lactulose/Mannitol ratioFecal calprotectin

Beyond the preview

Go deeper on Epithelial tight junction barrier (TJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epithelial tight junction barrier (TJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call